Skip to content
  • About us
    • Overview
    • Our founders
    • Careers
  • Our pipeline
    • Development pipeline
    • Netazepide
      • Background
      • Studies
      • Further studies
    • Ceclazepide
    • TR4
    • TR8
  • Trio Medicines Logo
  • Our publications
  • Contact us
Previous Next

Potential clinical indications for a CCK2 receptor antagonist.

Boyce M, Lloyd KA and Pritchard DM. Potential clinical indications for a CCK2 receptor antagonist.  Curr Opin Pharmacol 2016; 31:  63–75.

myarzi12019-03-26T13:07:10+00:00Netazepide|

Share This Story, Choose Your Platform!

FacebookTwitterLinkedInRedditGoogle+TumblrPinterestVkEmail